Allergy Vaccine Market Research Report by Allergy Type (Allergic Asthma, Cat Dander Allergy, Grass Pollen Hypersensitivity, Peanut Hypersensitivity, and Seasonal Allergic Rhinitis), by Vaccine Type (Cat Allergy Vaccine, House Dust Mite Allergy Vaccine, Injectable MPL Allergy Vaccine, Peanut Allergy Vaccine, and Ragweed Allergy Immunotherapy Vaccine), by Application, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Allergy Vaccine Market is expected to grow from USD 934.57 Million in 2020 to USD 1,538.46 Million by the end of 2025.
2. The Global Allergy Vaccine Market is expected to grow from EUR 819.45 Million in 2020 to EUR 1,348.95 Million by the end of 2025.
3. The Global Allergy Vaccine Market is expected to grow from GBP 728.49 Million in 2020 to GBP 1,199.22 Million by the end of 2025.
4. The Global Allergy Vaccine Market is expected to grow from JPY 99,742.87 Million in 2020 to JPY 164,193.21 Million by the end of 2025.
5. The Global Allergy Vaccine Market is expected to grow from AUD 1,357.12 Million in 2020 to AUD 2,234.05 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Allergy Vaccine to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Allergy Type, the Allergy Vaccine Market studied across Allergic Asthma, Cat Dander Allergy, Grass Pollen Hypersensitivity, Peanut Hypersensitivity, Seasonal Allergic Rhinitis, and Tree Pollen Hypersensitivity.
Based on Vaccine Type, the Allergy Vaccine Market studied across Cat Allergy Vaccine, House Dust Mite Allergy Vaccine, Injectable MPL Allergy Vaccine, Peanut Allergy Vaccine, and Ragweed Allergy Immunotherapy Vaccine.
Based on Application, the Allergy Vaccine Market studied across HIV, Oncology, and Respiratory.
Based on End User, the Allergy Vaccine Market studied across Homecare, Hospitals, and Specialty Clinics.
Based on Geography, the Allergy Vaccine Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Allergy Vaccine Market including Allergy Therapeutics, Allertein Therapeutics, Circassia, Cytos Biotechnology AG, DBV Technologies SA, Merck & Co., Inc., Novartis International AG, and Stallergenes Greer plc.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Allergy Vaccine Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Allergy Vaccine Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Allergy Vaccine Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Allergy Vaccine Market?
4. What is the competitive strategic window for opportunities in the Global Allergy Vaccine Market?
5. What are the technology trends and regulatory frameworks in the Global Allergy Vaccine Market?
6. What are the modes and strategic moves considered suitable for entering the Global Allergy Vaccine Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Allergy Vaccine Market is expected to grow from USD 934.57 Million in 2020 to USD 1,538.46 Million by the end of 2025.
2. The Global Allergy Vaccine Market is expected to grow from EUR 819.45 Million in 2020 to EUR 1,348.95 Million by the end of 2025.
3. The Global Allergy Vaccine Market is expected to grow from GBP 728.49 Million in 2020 to GBP 1,199.22 Million by the end of 2025.
4. The Global Allergy Vaccine Market is expected to grow from JPY 99,742.87 Million in 2020 to JPY 164,193.21 Million by the end of 2025.
5. The Global Allergy Vaccine Market is expected to grow from AUD 1,357.12 Million in 2020 to AUD 2,234.05 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Allergy Vaccine to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Allergy Type, the Allergy Vaccine Market studied across Allergic Asthma, Cat Dander Allergy, Grass Pollen Hypersensitivity, Peanut Hypersensitivity, Seasonal Allergic Rhinitis, and Tree Pollen Hypersensitivity.
Based on Vaccine Type, the Allergy Vaccine Market studied across Cat Allergy Vaccine, House Dust Mite Allergy Vaccine, Injectable MPL Allergy Vaccine, Peanut Allergy Vaccine, and Ragweed Allergy Immunotherapy Vaccine.
Based on Application, the Allergy Vaccine Market studied across HIV, Oncology, and Respiratory.
Based on End User, the Allergy Vaccine Market studied across Homecare, Hospitals, and Specialty Clinics.
Based on Geography, the Allergy Vaccine Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Allergy Vaccine Market including Allergy Therapeutics, Allertein Therapeutics, Circassia, Cytos Biotechnology AG, DBV Technologies SA, Merck & Co., Inc., Novartis International AG, and Stallergenes Greer plc.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Allergy Vaccine Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Allergy Vaccine Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Allergy Vaccine Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Allergy Vaccine Market?
4. What is the competitive strategic window for opportunities in the Global Allergy Vaccine Market?
5. What are the technology trends and regulatory frameworks in the Global Allergy Vaccine Market?
6. What are the modes and strategic moves considered suitable for entering the Global Allergy Vaccine Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Allergy Type Outlook
3.4. Vaccine Type Outlook
3.5. Application Outlook
3.6. End User Outlook
3.7. Geography Outlook
3.8. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of allergies globally
5.1.1.2. Increasing air pollution with industrialization coupled with growing tobacco consumption
5.1.1.3. Rising awareness among consumers about the allergies
5.1.2. Restraints
5.1.2.1. Limited allergy vaccine manufacturers
5.1.3. Opportunities
5.1.3.1. Research and development for the production of specific allergy vaccine
5.1.3.2. Government and private sector initiatives in the production of vaccines
5.1.4. Challenges
5.1.4.1. Capital intensive in the production of allergy vaccines
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL ALLERGY VACCINE MARKET, BY ALLERGY TYPE
6.1. Introduction
6.2. Allergic Asthma
6.3. Cat Dander Allergy
6.4. Grass Pollen Hypersensitivity
6.5. Peanut Hypersensitivity
6.6. Seasonal Allergic Rhinitis
6.7. Tree Pollen Hypersensitivity
7. GLOBAL ALLERGY VACCINE MARKET, BY VACCINE TYPE
7.1. Introduction
7.2. Cat Allergy Vaccine
7.3. House Dust Mite Allergy Vaccine
7.4. Injectable MPL Allergy Vaccine
7.5. Peanut Allergy Vaccine
7.6. Ragweed Allergy Immunotherapy Vaccine
8. GLOBAL ALLERGY VACCINE MARKET, BY APPLICATION
8.1. Introduction
8.2. HIV
8.3. Oncology
8.4. Respiratory
9. GLOBAL ALLERGY VACCINE MARKET, BY END USER
9.1. Introduction
9.2. Homecare
9.3. Hospitals
9.4. Specialty Clinics
10. AMERICAS ALLERGY VACCINE MARKET
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. ASIA-PACIFIC ALLERGY VACCINE MARKET
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. South Korea
11.10. Thailand
12. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. COMPETITIVE LANDSCAPE
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis
13.4. Competitor SWOT Analysis
13.5. Competitive Scenario
13.5.1. Merger & Acquisition
13.5.2. Agreement, Collaboration, & Partnership
13.5.3. New Product Launch & Enhancement
13.5.4. Investment & Funding
13.5.5. Award, Recognition, & Expansion
14. COMPANY USABILITY PROFILES
14.1. Allergy Therapeutics
14.2. Allertein Therapeutics
14.3. Circassia
14.4. Cytos Biotechnology AG
14.5. DBV Technologies SA
14.6. Merck & Co., Inc.
14.7. Novartis International AG
14.8. Stallergenes Greer plc
15. APPENDIX
15.1. Discussion Guide
15.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Allergy Type Outlook
3.4. Vaccine Type Outlook
3.5. Application Outlook
3.6. End User Outlook
3.7. Geography Outlook
3.8. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of allergies globally
5.1.1.2. Increasing air pollution with industrialization coupled with growing tobacco consumption
5.1.1.3. Rising awareness among consumers about the allergies
5.1.2. Restraints
5.1.2.1. Limited allergy vaccine manufacturers
5.1.3. Opportunities
5.1.3.1. Research and development for the production of specific allergy vaccine
5.1.3.2. Government and private sector initiatives in the production of vaccines
5.1.4. Challenges
5.1.4.1. Capital intensive in the production of allergy vaccines
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL ALLERGY VACCINE MARKET, BY ALLERGY TYPE
6.1. Introduction
6.2. Allergic Asthma
6.3. Cat Dander Allergy
6.4. Grass Pollen Hypersensitivity
6.5. Peanut Hypersensitivity
6.6. Seasonal Allergic Rhinitis
6.7. Tree Pollen Hypersensitivity
7. GLOBAL ALLERGY VACCINE MARKET, BY VACCINE TYPE
7.1. Introduction
7.2. Cat Allergy Vaccine
7.3. House Dust Mite Allergy Vaccine
7.4. Injectable MPL Allergy Vaccine
7.5. Peanut Allergy Vaccine
7.6. Ragweed Allergy Immunotherapy Vaccine
8. GLOBAL ALLERGY VACCINE MARKET, BY APPLICATION
8.1. Introduction
8.2. HIV
8.3. Oncology
8.4. Respiratory
9. GLOBAL ALLERGY VACCINE MARKET, BY END USER
9.1. Introduction
9.2. Homecare
9.3. Hospitals
9.4. Specialty Clinics
10. AMERICAS ALLERGY VACCINE MARKET
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. ASIA-PACIFIC ALLERGY VACCINE MARKET
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. South Korea
11.10. Thailand
12. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. COMPETITIVE LANDSCAPE
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis
13.4. Competitor SWOT Analysis
13.5. Competitive Scenario
13.5.1. Merger & Acquisition
13.5.2. Agreement, Collaboration, & Partnership
13.5.3. New Product Launch & Enhancement
13.5.4. Investment & Funding
13.5.5. Award, Recognition, & Expansion
14. COMPANY USABILITY PROFILES
14.1. Allergy Therapeutics
14.2. Allertein Therapeutics
14.3. Circassia
14.4. Cytos Biotechnology AG
14.5. DBV Technologies SA
14.6. Merck & Co., Inc.
14.7. Novartis International AG
14.8. Stallergenes Greer plc
15. APPENDIX
15.1. Discussion Guide
15.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL ALLERGY VACCINE MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGIC ASTHMA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL ALLERGY VACCINE MARKET SIZE, BY CAT DANDER ALLERGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL ALLERGY VACCINE MARKET SIZE, BY GRASS POLLEN HYPERSENSITIVITY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PEANUT HYPERSENSITIVITY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGIC RHINITIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL ALLERGY VACCINE MARKET SIZE, BY TREE POLLEN HYPERSENSITIVITY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL ALLERGY VACCINE MARKET SIZE, BY CAT ALLERGY VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOUSE DUST MITE ALLERGY VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL ALLERGY VACCINE MARKET SIZE, BY INJECTABLE MPL ALLERGY VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PEANUT ALLERGY VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL ALLERGY VACCINE MARKET SIZE, BY RAGWEED ALLERGY IMMUNOTHERAPY VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HIV, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL ALLERGY VACCINE MARKET SIZE, BY RESPIRATORY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOMECARE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SPECIALTY CLINICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. AMERICAS ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. AMERICAS ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. AMERICAS ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. AMERICAS ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. AMERICAS ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. BRAZIL ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. BRAZIL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. BRAZIL ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. BRAZIL ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. CANADA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. CANADA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. CANADA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. CANADA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. MEXICO ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. MEXICO ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. MEXICO ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. MEXICO ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. AUSTRALIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. AUSTRALIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. AUSTRALIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. AUSTRALIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. CHINA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. CHINA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. CHINA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. CHINA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. INDIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. INDIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. INDIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. INDIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. INDONESIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. INDONESIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. INDONESIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. INDONESIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. JAPAN ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. JAPAN ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. JAPAN ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. JAPAN ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. MALAYSIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. MALAYSIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. MALAYSIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. MALAYSIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. PHILIPPINES ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. PHILIPPINES ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. PHILIPPINES ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. PHILIPPINES ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. SOUTH KOREA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. SOUTH KOREA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. SOUTH KOREA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. SOUTH KOREA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. THAILAND ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. THAILAND ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. THAILAND ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. THAILAND ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. FRANCE ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. FRANCE ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. FRANCE ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. FRANCE ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. GERMANY ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. GERMANY ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. GERMANY ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. GERMANY ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. ITALY ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. ITALY ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. ITALY ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. ITALY ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. NETHERLANDS ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. NETHERLANDS ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. NETHERLANDS ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. NETHERLANDS ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. QATAR ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. QATAR ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. QATAR ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. QATAR ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. RUSSIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. RUSSIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. RUSSIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. RUSSIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. SAUDI ARABIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. SAUDI ARABIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. SAUDI ARABIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. SAUDI ARABIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. SOUTH AFRICA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. SOUTH AFRICA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. SOUTH AFRICA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. SOUTH AFRICA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. SPAIN ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. SPAIN ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. SPAIN ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. SPAIN ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. UNITED ARAB EMIRATES ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. UNITED ARAB EMIRATES ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. UNITED ARAB EMIRATES ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 135. UNITED ARAB EMIRATES ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 136. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 137. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 138. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 139. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 140. GLOBAL ALLERGY VACCINE MARKET: SCORES
TABLE 141. GLOBAL ALLERGY VACCINE MARKET: BUSINESS STRATEGY
TABLE 142. GLOBAL ALLERGY VACCINE MARKET: PRODUCT SATISFACTION
TABLE 143. GLOBAL ALLERGY VACCINE MARKET: RANKING
TABLE 144. GLOBAL ALLERGY VACCINE MARKET: MERGER & ACQUISITION
TABLE 145. GLOBAL ALLERGY VACCINE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 146. GLOBAL ALLERGY VACCINE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 147. GLOBAL ALLERGY VACCINE MARKET: INVESTMENT & FUNDING
TABLE 148. GLOBAL ALLERGY VACCINE MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 149. GLOBAL ALLERGY VACCINE MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL ALLERGY VACCINE MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGIC ASTHMA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL ALLERGY VACCINE MARKET SIZE, BY CAT DANDER ALLERGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL ALLERGY VACCINE MARKET SIZE, BY GRASS POLLEN HYPERSENSITIVITY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PEANUT HYPERSENSITIVITY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGIC RHINITIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL ALLERGY VACCINE MARKET SIZE, BY TREE POLLEN HYPERSENSITIVITY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL ALLERGY VACCINE MARKET SIZE, BY CAT ALLERGY VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOUSE DUST MITE ALLERGY VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL ALLERGY VACCINE MARKET SIZE, BY INJECTABLE MPL ALLERGY VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PEANUT ALLERGY VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL ALLERGY VACCINE MARKET SIZE, BY RAGWEED ALLERGY IMMUNOTHERAPY VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HIV, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL ALLERGY VACCINE MARKET SIZE, BY RESPIRATORY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOMECARE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SPECIALTY CLINICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. AMERICAS ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. AMERICAS ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. AMERICAS ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. AMERICAS ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. AMERICAS ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. BRAZIL ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. BRAZIL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. BRAZIL ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. BRAZIL ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. CANADA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. CANADA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. CANADA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. CANADA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. MEXICO ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. MEXICO ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. MEXICO ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. MEXICO ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. AUSTRALIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. AUSTRALIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. AUSTRALIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. AUSTRALIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. CHINA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. CHINA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. CHINA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. CHINA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. INDIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. INDIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. INDIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. INDIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. INDONESIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. INDONESIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. INDONESIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. INDONESIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. JAPAN ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. JAPAN ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. JAPAN ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. JAPAN ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. MALAYSIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. MALAYSIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. MALAYSIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. MALAYSIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. PHILIPPINES ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. PHILIPPINES ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. PHILIPPINES ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. PHILIPPINES ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. SOUTH KOREA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. SOUTH KOREA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. SOUTH KOREA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. SOUTH KOREA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. THAILAND ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. THAILAND ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. THAILAND ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. THAILAND ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. FRANCE ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. FRANCE ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. FRANCE ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. FRANCE ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. GERMANY ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. GERMANY ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. GERMANY ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. GERMANY ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. ITALY ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. ITALY ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. ITALY ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. ITALY ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. NETHERLANDS ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. NETHERLANDS ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. NETHERLANDS ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. NETHERLANDS ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. QATAR ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. QATAR ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. QATAR ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. QATAR ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. RUSSIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. RUSSIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. RUSSIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. RUSSIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. SAUDI ARABIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. SAUDI ARABIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. SAUDI ARABIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. SAUDI ARABIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. SOUTH AFRICA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. SOUTH AFRICA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. SOUTH AFRICA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. SOUTH AFRICA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. SPAIN ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. SPAIN ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. SPAIN ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. SPAIN ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. UNITED ARAB EMIRATES ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. UNITED ARAB EMIRATES ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. UNITED ARAB EMIRATES ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 135. UNITED ARAB EMIRATES ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 136. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 137. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 138. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 139. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 140. GLOBAL ALLERGY VACCINE MARKET: SCORES
TABLE 141. GLOBAL ALLERGY VACCINE MARKET: BUSINESS STRATEGY
TABLE 142. GLOBAL ALLERGY VACCINE MARKET: PRODUCT SATISFACTION
TABLE 143. GLOBAL ALLERGY VACCINE MARKET: RANKING
TABLE 144. GLOBAL ALLERGY VACCINE MARKET: MERGER & ACQUISITION
TABLE 145. GLOBAL ALLERGY VACCINE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 146. GLOBAL ALLERGY VACCINE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 147. GLOBAL ALLERGY VACCINE MARKET: INVESTMENT & FUNDING
TABLE 148. GLOBAL ALLERGY VACCINE MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 149. GLOBAL ALLERGY VACCINE MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL ALLERGY VACCINE MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ALLERGY VACCINE MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL ALLERGY VACCINE MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2020 (USD MILLION)
FIGURE 6. GLOBAL ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 7. GLOBAL ALLERGY VACCINE MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 8. GLOBAL ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 9. GLOBAL ALLERGY VACCINE MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 10. GLOBAL ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 11. GLOBAL ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 13. GLOBAL ALLERGY VACCINE MARKET: MARKET DYNAMICS
FIGURE 14. GLOBAL ALLERGY VACCINE MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 15. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2020 VS 2025 (%)
FIGURE 16. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2025
FIGURE 18. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGIC ASTHMA, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL ALLERGY VACCINE MARKET SIZE, BY CAT DANDER ALLERGY, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL ALLERGY VACCINE MARKET SIZE, BY GRASS POLLEN HYPERSENSITIVITY, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PEANUT HYPERSENSITIVITY, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGIC RHINITIS, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL ALLERGY VACCINE MARKET SIZE, BY TREE POLLEN HYPERSENSITIVITY, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2020 VS 2025 (%)
FIGURE 25. GLOBAL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2025
FIGURE 27. GLOBAL ALLERGY VACCINE MARKET SIZE, BY CAT ALLERGY VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOUSE DUST MITE ALLERGY VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL ALLERGY VACCINE MARKET SIZE, BY INJECTABLE MPL ALLERGY VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PEANUT ALLERGY VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL ALLERGY VACCINE MARKET SIZE, BY RAGWEED ALLERGY IMMUNOTHERAPY VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
FIGURE 33. GLOBAL ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2025
FIGURE 35. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HIV, 2020 VS 2025 (USD MILLION)
FIGURE 36. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ONCOLOGY, 2020 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL ALLERGY VACCINE MARKET SIZE, BY RESPIRATORY, 2020 VS 2025 (USD MILLION)
FIGURE 38. GLOBAL ALLERGY VACCINE MARKET SIZE, BY END USER, 2020 VS 2025 (%)
FIGURE 39. GLOBAL ALLERGY VACCINE MARKET SIZE, BY END USER, 2020 VS 2025 (USD MILLION)
FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY VACCINE MARKET SIZE, BY END USER, 2025
FIGURE 41. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOMECARE, 2020 VS 2025 (USD MILLION)
FIGURE 42. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOSPITALS, 2020 VS 2025 (USD MILLION)
FIGURE 43. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SPECIALTY CLINICS, 2020 VS 2025 (USD MILLION)
FIGURE 44. AMERICAS ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 45. AMERICAS ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 47. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. BRAZIL ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. CANADA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. MEXICO ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 53. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 55. AUSTRALIA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. CHINA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. INDIA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. INDONESIA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. JAPAN ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. MALAYSIA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. PHILIPPINES ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. SOUTH KOREA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. THAILAND ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 65. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 66. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 67. FRANCE ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. GERMANY ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. ITALY ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. NETHERLANDS ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. QATAR ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. RUSSIA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 73. SAUDI ARABIA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 74. SOUTH AFRICA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 75. SPAIN ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 76. UNITED ARAB EMIRATES ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 77. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 78. GLOBAL ALLERGY VACCINE MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 79. GLOBAL ALLERGY VACCINE MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 80. GLOBAL ALLERGY VACCINE MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 81. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ALLERGY VACCINE MARKET, BY TYPE
FIGURE 1. GLOBAL ALLERGY VACCINE MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ALLERGY VACCINE MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL ALLERGY VACCINE MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2020 (USD MILLION)
FIGURE 6. GLOBAL ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 7. GLOBAL ALLERGY VACCINE MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 8. GLOBAL ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 9. GLOBAL ALLERGY VACCINE MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 10. GLOBAL ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 11. GLOBAL ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 13. GLOBAL ALLERGY VACCINE MARKET: MARKET DYNAMICS
FIGURE 14. GLOBAL ALLERGY VACCINE MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 15. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2020 VS 2025 (%)
FIGURE 16. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2025
FIGURE 18. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ALLERGIC ASTHMA, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL ALLERGY VACCINE MARKET SIZE, BY CAT DANDER ALLERGY, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL ALLERGY VACCINE MARKET SIZE, BY GRASS POLLEN HYPERSENSITIVITY, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PEANUT HYPERSENSITIVITY, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGIC RHINITIS, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL ALLERGY VACCINE MARKET SIZE, BY TREE POLLEN HYPERSENSITIVITY, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2020 VS 2025 (%)
FIGURE 25. GLOBAL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2025
FIGURE 27. GLOBAL ALLERGY VACCINE MARKET SIZE, BY CAT ALLERGY VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOUSE DUST MITE ALLERGY VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL ALLERGY VACCINE MARKET SIZE, BY INJECTABLE MPL ALLERGY VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL ALLERGY VACCINE MARKET SIZE, BY PEANUT ALLERGY VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL ALLERGY VACCINE MARKET SIZE, BY RAGWEED ALLERGY IMMUNOTHERAPY VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
FIGURE 33. GLOBAL ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2025
FIGURE 35. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HIV, 2020 VS 2025 (USD MILLION)
FIGURE 36. GLOBAL ALLERGY VACCINE MARKET SIZE, BY ONCOLOGY, 2020 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL ALLERGY VACCINE MARKET SIZE, BY RESPIRATORY, 2020 VS 2025 (USD MILLION)
FIGURE 38. GLOBAL ALLERGY VACCINE MARKET SIZE, BY END USER, 2020 VS 2025 (%)
FIGURE 39. GLOBAL ALLERGY VACCINE MARKET SIZE, BY END USER, 2020 VS 2025 (USD MILLION)
FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY VACCINE MARKET SIZE, BY END USER, 2025
FIGURE 41. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOMECARE, 2020 VS 2025 (USD MILLION)
FIGURE 42. GLOBAL ALLERGY VACCINE MARKET SIZE, BY HOSPITALS, 2020 VS 2025 (USD MILLION)
FIGURE 43. GLOBAL ALLERGY VACCINE MARKET SIZE, BY SPECIALTY CLINICS, 2020 VS 2025 (USD MILLION)
FIGURE 44. AMERICAS ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 45. AMERICAS ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 47. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. BRAZIL ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. CANADA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. MEXICO ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 53. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 55. AUSTRALIA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. CHINA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. INDIA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. INDONESIA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. JAPAN ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. MALAYSIA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. PHILIPPINES ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. SOUTH KOREA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. THAILAND ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 65. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 66. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 67. FRANCE ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. GERMANY ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. ITALY ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. NETHERLANDS ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. QATAR ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. RUSSIA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 73. SAUDI ARABIA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 74. SOUTH AFRICA ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 75. SPAIN ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 76. UNITED ARAB EMIRATES ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 77. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 78. GLOBAL ALLERGY VACCINE MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 79. GLOBAL ALLERGY VACCINE MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 80. GLOBAL ALLERGY VACCINE MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 81. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ALLERGY VACCINE MARKET, BY TYPE
